成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
上海一飛生物科技有限公司 公司信息
公司名稱:
上海一飛生物科技有限公司
電話:
021-65675885
電子郵件:
customer_service@efebio.com
國籍:
中國
網(wǎng)址:
http://www.efebio.com
產(chǎn)品總數(shù):
11974
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
公司提供產(chǎn)品列表
RS1-PDK1 inhibitor
N-(6-chloro-1,3-benzothiazol-2-yl)-1-benzothiophene-3-sulfonamide
1643958-85-3
PDK1-IN-RS2
PDK1-IN-RS2
1643958-89-7
TDRL-551
化合物 T28935
1644626-43-6
HTL14242
Benzonitrile, 3-chloro-5-[6-(5-fluoro-2-pyridinyl)-4-pyrimidinyl]-
1644645-32-8
DA-6886
1645260-76-9
1645260-76-9
Eptinezumab
依普奈珠單抗
1644539-04-7
(R)-AZD 9639
化合物 (R)-AZD 9639
1646857-28-4
BTA-9881
化合物 T26914
1646857-24-0
Tomuzotuximab
Tomuzotuximab
1646321-00-7
(Rac)-MEM 1003
3,5-Pyridinedicarboxylic acid, 4-(2-chloro-3-cyanophenyl)-1,4-dihydro-2,6-dimethyl-, 3-(2-methoxyethyl) 5-(1-methylethyl) ester
165187-25-7
ACT-660602
化合物 ACT-660602
1646267-59-5
Fremanezumab
瑞瑪奈珠單抗
1655501-53-3
FD-IN-1
FD-IN-1
1646682-14-5
Gimsilumab
瑾司魯單抗
1648796-29-5
Delmetacin
地美辛
16401-80-2
Inotuzumab
英妥珠單抗
1660159-36-3
CRT-0105950
CRT-0105950 (CRT0105950)
1661845-86-8
Parthenosin
b-D-Glucopyranosiduronic acid,2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl, butyl ester
166196-16-3
Flotetuzumab
Flotetuzumab
1664355-28-5
(Rac)-Naxifylline
NAXIFYLLINE異構體
166181-76-6
NDB
NDB
1660153-08-1
Fluoroethylnormemantine
FLUOROETHYLNORMEMANTINE
1639210-26-6
Lupartumab
Lupartumab
1640971-88-5
Relatlimab
Relatlimab
1673516-98-7
AGN 192870
化合物 AGN 192870
166977-57-7
BrBzGCp2
S-4-bromobenzylglutathione cyclopentyl diester
166038-00-2
Timigutuzumab
Timigutuzumab
1665274-14-5
CT-2584
1H-Purine-2,6-dione, 1-[11-(dodecylamino)-10-hydroxyundecyl]-3,7-dihydro-3,7-dimethyl-
166981-13-1
Enrasentan
1H-Indene-2-carboxylicacid,1-(1,3-benzodioxol-5-yl)-2,3-dihydro-3-[2-(2-hydroxyethoxy)-4-methoxyphenyl]-5-propoxy-,(1S,2R,3S)-
167256-08-8
TGP-377/421
化合物 TGP-377/421
16752-89-9
Talastine
他拉斯汀
16188-61-7
UCM-13207
化合物 UCM-13207
1621536-10-4
Isolupalbigenin
ISOLUPALBIGENIN
162616-70-8
AC 7739
化合物 AC 7739
162705-22-8
JG-231
JG-231
1627126-59-3
Zilovertamab
澤羅妥單抗
1643432-38-5
Leramistat
HMC-C-01-A|||MBS2320
1642602-54-7
TL4-12
化合物 T26280
1620820-12-3
Honokiol DCA
Acetic acid, 2,2-dichloro-, 2'-[(2,2-dichloroacetyl)oxy]-3,5'-di-2-propen-1-yl[1,1'-biphenyl]-4-yl ester
1620160-42-0
Gü2602
化合物 Gü2602
1627094-88-5
(Rac)-Telinavir
化合物 (RAC)-TELINAVIR
162679-88-1
GNE-8505
GNE-8505
1620573-48-9
TASP0390325
2-(3-Chloro-4-fluorophenyl)-N-(1-methylethyl)-6-[3-(4-morpholinyl)propoxy]-4-oxo-pyrido[2,3-d]pyrimidine-3(4H)-acetamide hydrochloride
1642187-96-9
Zectivimod
ZECTIVIMOD
1623066-63-6
SLMP53-1
化合物 SLMP53-1
1643469-17-3
Naratuximab
那妥昔單抗
1622327-39-2
hTYR/AbTYR-IN-1
HTYR/ABTYR抑制劑1
1625821-37-5
Selicrelumab
塞魯單抗
1622140-49-1
ZEN-3694
ZEN 3694
1643947-30-1
Clivatuzumab
克利妥珠單抗
1622075-09-5
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride
3-(哌啶-4-基)苯并[D]噁唑-2(3H)-酮鹽酸鹽
162045-54-7
Rivabazumab
Rivabazumab
1627519-84-9
PW0464
PW0464
1643462-93-4
Azido-PEG3-C6-Cl
疊氮-三聚乙二醇-C6-氯
1625717-44-3
L-372662
化合物 T32497
162045-26-3
Nav1.8-IN-4
2-(4-氟-2-甲基苯氧基)-N-(2-氧代-1,2-二氫吡啶-4-基)-4-(三氟甲基)苯甲酰胺
1620846-16-3
Glycopyrronium tosylate
格隆銨甲苯磺酸鹽
1624259-25-1
GPR81 agonist 1
化合物 GPR81 AGONIST 1
1620992-67-7
Laprituximab
Laprituximab
1622327-38-1
Frovocimab
Frovocimab
1643672-70-1
ABI-1968
1626364-18-8
1626364-18-8
Elsubrutinib
ELSUBRUTINIB
1643570-24-4
Karavilagenin F
Karavilagenin F
1639024-15-9
Aprutumab
阿普盧妥單抗
1634620-63-5
UniPR129
化合物 T26310
1639159-47-9
GBT1118
化合物 GBT1118
1628799-51-8
Itacnosertib
N4-([2,2-bipyridin]-3-yl)-N2-(3-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-2,4-diamine
1628870-27-8
Ralaniten triacetate
RALANITEN TRIACETATE
1637573-04-6
Ranevetmab
Ranevetmab
1632282-27-9
Tavolixizumab
Tavolimab
1635395-25-3
MAO-B-IN-8
化合物 MAO-B-IN-8
1638956-60-1
KZR-504
KZR-504
1629052-78-3
(R)-DNMDP
(R)-DNMDP
1630760-60-9
Ladiratuzumab
LADIRATUZUMAB (ANTI-SLC39A6)
1629760-28-6
TAK-020
化合物TAK-020
1627603-21-7
Talviraline
HBY 097
163451-80-7
Vonlerolizumab
Vonlerolizumab
1638935-72-4
Suvratoxumab
Suvratoxumab
1629620-18-3
MLK-IN-1
N-(3,4-二甲氧基苯基)-3-(7-甲氧基苯并[B]噻吩-2-基)咪唑并[1,2-B]噠嗪-6-胺
1627729-62-7
Fluoroethylnormemantine hydrochloride
FLUOROETHYLNORMEMANTINE HYDROCHLORIDE
1639210-25-5
Dalzanemdor
化合物 DALZANEMDOR
1629853-48-0
pan-HER-IN-2
化合物 PAN-HER-IN-2
1639040-95-1
BDBM50597431
化合物BDBM50597431
1629853-49-1
Nerelimomab
Nerelimomab [usan:inn]
162774-06-3
Dapson-13C12
氨苯砜(13C12)
1632119-29-9
ALDH2 modulator 1
ALDH2調節(jié)劑1
1629615-99-1
Suptavumab
Suptavumab
1629615-23-1
VU0453379
VU0453379
1638646-27-1
Cipepofol
化合物 T32105
1637741-58-2
GS-626510
GS-626510
1637770-13-8
DI-82
DI-82
1638148-50-1
Osimertinib-d6
奧希替尼雜質28
1638281-44-3
FGFR4-IN-5
FGFR4-IN-5
1628793-01-0
DHODH-IN-17
化合物 DHODH-IN-17
16344-26-6
Otilimab
對照抗體
1638332-55-4
Navicixizumab
Navicixizumab
1638338-43-8
Ibiglustat succinate
IBIGLUSTAT SUCCINATE
1629063-80-4
Vobarilizumab
Vobarilizumab
1628814-88-9
URAT1 inhibitor 7
URAT1 INHIBITOR 7
1632002-28-8
CPL304110
化合物 CPL304110
1627826-19-0
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Copyright 2007? ChemicalBook. All rights reserved.